Bernard Lam

5PUBLICATIONS
99CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 23, 2024
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors.

Eric Y Stutheit-Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu

|Oct 24, 2023
Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA.

Derek Wong, Ping Luo, Leslie E Oldfield

|Aug 11, 2023
Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial.

Abdulazeez Salawu, Ben X Wang, Ming Han

|Jun 16, 2023
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression.

Stephanie Lheureux, Stephenie D Prokopec, Leslie E Oldfield

|Oct 12, 2022
hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma.

Sheron Perera, Gun Ho Jang, Yifan Wang

Pageof 1